Contact this trialFirst, we need to learn more about you.
Chemotherapy
Parsaclisib + Standard Therapy for Non-Hodgkin's Lymphoma
Recruiting1 awardPhase 1
Scottsdale, Arizona
This trial is testing a new drug called parsaclisib, sometimes combined with polatuzumab-vedotin, along with standard cancer drugs in patients with high-risk diffuse large B-cell lymphoma. Parsaclisib blocks enzymes that help cancer grow, while polatuzumab-vedotin targets and kills cancer cells. The goal is to see if this combination works better than the standard treatment alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service